Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 530

1.

Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.

Honselmann KC, Pergolini I, Castillo CF, Deshpande V, Ting D, Taylor MS, Bolm L, Qadan M, Wellner U, Sandini M, Bausch D, Warshaw AL, Lillemoe KD, Keck T, Ferrone CR.

Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003123. [Epub ahead of print]

PMID:
30672796
2.

Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).

Cai L, Michelakos T, Deshpande V, Arora KS, Yamada T, Ting DT, Taylor MS, Castillo CF, Warshaw AL, Lillemoe KD, Ferrone S, Ferrone CR.

Clin Cancer Res. 2019 Apr 15;25(8):2644-2655. doi: 10.1158/1078-0432.CCR-18-1401. Epub 2019 Jan 22.

PMID:
30670493
3.

Total pancreatectomy for pancreatic malignancy with preservation of the spleen.

Yang F, Jin C, Warshaw AL, You L, Mao Y, Fu D.

J Surg Oncol. 2019 May;119(6):784-793. doi: 10.1002/jso.25377. Epub 2019 Jan 12.

PMID:
30636049
4.

Lower phosphate levels following pancreatectomy is associated with postoperative pancreatic fistula formation.

Mueller JL, Chang DC, Fernandez-Del Castillo C, Ferrone CR, Warshaw AL, Lillemoe KD, Qadan M.

HPB (Oxford). 2018 Nov 29. pii: S1365-182X(18)34524-6. doi: 10.1016/j.hpb.2018.10.017. [Epub ahead of print]

PMID:
30503649
5.

Intraoperative Fluid Administration and Surgical Outcomes Following Pancreaticoduodenectomy: External Validation at a Tertiary Referral Center.

Sandini M, Fernández-Del Castillo C, Ferrone CR, Ruscic KJ, Eikermann M, Warshaw AL, Lillemoe KD, Qadan M.

World J Surg. 2019 Mar;43(3):929-936. doi: 10.1007/s00268-018-4842-0.

PMID:
30377724
6.

Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis.

Malleo G, Maggino L, Ferrone CR, Marchegiani G, Warshaw AL, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003083. [Epub ahead of print]

PMID:
30339622
7.

Intraoperative Dexamethasone Decreases Infectious Complications After Pancreaticoduodenectomy and is Associated with Long-Term Survival in Pancreatic Cancer.

Sandini M, Ruscic KJ, Ferrone CR, Warshaw AL, Qadan M, Eikermann M, Lillemoe KD, Fernández-Del Castillo C.

Ann Surg Oncol. 2018 Dec;25(13):4020-4026. doi: 10.1245/s10434-018-6827-5. Epub 2018 Oct 8.

PMID:
30298316
8.

Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?

Mehtsun WT, Chipidza FE, Fernández-Del Castillo C, Hemingway K, Fong ZV, Chang DC, Pandharipande P, Clark JW, Allen J, Hong TS, Wo JY, Warshaw AL, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2018 Dec;25(13):3936-3942. doi: 10.1245/s10434-018-6764-3. Epub 2018 Oct 1.

PMID:
30276641
9.

Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer.

Sandini M, Ruscic KJ, Ferrone CR, Qadan M, Eikermann M, Warshaw AL, Lillemoe KD, Castillo CF.

J Gastrointest Surg. 2018 Sep 17. doi: 10.1007/s11605-018-3939-y. [Epub ahead of print]

PMID:
30225794
10.

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

Luo G, Fan Z, Cheng H, Jin K, Guo M, Lu Y, Yang C, Fan K, Huang Q, Long J, Liu L, Xu J, Lu R, Ni Q, Warshaw AL, Liu C, Yu X.

Pancreatology. 2018 Dec;18(8):971-976. doi: 10.1016/j.pan.2018.08.003. Epub 2018 Aug 9.

PMID:
30131287
11.

Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer.

Sell NM, Fong ZV, Del Castillo CF, Qadan M, Warshaw AL, Chang D, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2018 Apr;25(4):1009-1016. doi: 10.1245/s10434-017-6317-1. Epub 2018 Jan 31.

PMID:
29388123
12.

Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations.

Morales-Oyarvide V, Fong ZV, Fernández-Del Castillo C, Warshaw AL.

Visc Med. 2017 Dec;33(6):466-476. doi: 10.1159/000485014. Epub 2017 Dec 8.

13.

Prevent the Bleed: How Surgeons Can Lead the National Conversation About Firearm Safety Forward.

Maa J, Masiakos PT, Elsey JK, Warshaw AL.

Ann Surg. 2018 Mar;267(3):428-429. doi: 10.1097/SLA.0000000000002638.

PMID:
29252222
14.

Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.

Michelakos T, Pergolini I, Castillo CF, Honselmann KC, Cai L, Deshpande V, Wo JY, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Nipp RD, Parikh A, Qadan M, Warshaw AL, Hong TS, Lillemoe KD, Ferrone CR.

Ann Surg. 2019 Apr;269(4):733-740. doi: 10.1097/SLA.0000000000002600.

PMID:
29227344
15.

Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Sahani DV, Pergolini I, Attiyeh MA, Al Efishat M, Rezaee N, Hruban RH, He J, Weiss MJ, Allen PJ, Wolfgang CL, Fernández-Del Castillo C.

J Gastrointest Surg. 2018 Feb;22(2):226-234. doi: 10.1007/s11605-017-3602-z. Epub 2017 Oct 18.

PMID:
29047068
16.

Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Sahani DV, Pergolini I, Negreros-Osuna AA, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Pancreatology. 2017 Nov - Dec;17(6):920-926. doi: 10.1016/j.pan.2017.08.073. Epub 2017 Sep 8.

PMID:
28890154
17.

Appropriate Surgical Care: Who Decides?: The I. Ridgeway Trimble Lecture.

Warshaw AL.

Ann Surg. 2018 Feb;267(2S Suppl 2):S52-S54. doi: 10.1097/SLA.0000000000002516. No abstract available.

PMID:
28885507
18.

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.

Pergolini I, Morales-Oyarvide V, Mino-Kenudson M, Honselmann KC, Rosenbaum MW, Nahar S, Kem M, Ferrone CR, Lillemoe KD, Bardeesy N, Ryan DP, Thayer SP, Warshaw AL, Fernández-Del Castillo C, Liss AS.

PLoS One. 2017 Aug 30;12(8):e0182855. doi: 10.1371/journal.pone.0182855. eCollection 2017.

19.

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Gastroenterology. 2017 Nov;153(5):1284-1294.e1. doi: 10.1053/j.gastro.2017.07.019. Epub 2017 Jul 21.

PMID:
28739282
20.

Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients.

Fong ZV, Alvino DML, Fernández-Del Castillo C, Mehtsun WT, Pergolini I, Warshaw AL, Chang DC, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2017 Oct;24(11):3203-3211. doi: 10.1245/s10434-017-5973-5. Epub 2017 Jul 17.

PMID:
28718038
21.

Primary lymph node gastrinoma: A single institution experience.

Chen Y, Deshpande V, Ferrone C, Blaszkowsky LS, Parangi S, Warshaw AL, Lillemoe KD, Fernandez-Del Castillo C.

Surgery. 2017 Nov;162(5):1088-1094. doi: 10.1016/j.surg.2017.05.017. Epub 2017 Jul 10.

PMID:
28705492
22.

Is Annual Volume Enough? The Role of Experience and Specialization on Inpatient Mortality After Hepatectomy.

Hashimoto DA, Bababekov YJ, Mehtsun WT, Stapleton SM, Warshaw AL, Lillemoe KD, Chang DC, Vagefi PA.

Ann Surg. 2017 Oct;266(4):603-609. doi: 10.1097/SLA.0000000000002377.

23.

Health-related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy.

Fong ZV, Alvino DM, Castillo CF, Nipp RD, Traeger LN, Ruddy M, Lubitz CC, Johnson CD, Chang DC, Warshaw AL, Lillemoe KD, Ferrone CR.

Ann Surg. 2017 Oct;266(4):685-692. doi: 10.1097/SLA.0000000000002380.

PMID:
28657944
24.

Addressing the Public Health Epidemic of Firearm-related Violence in America.

Masiakos PT, Warshaw AL.

Ann Surg. 2018 Jul;268(1):e15. doi: 10.1097/SLA.0000000000002299. No abstract available.

PMID:
28514283
25.

Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy.

Fong ZV, Loehrer AP, Fernández-Del Castillo C, Bababekov YJ, Jin G, Ferrone CR, Warshaw AL, Traeger LN, Hutter MM, Lillemoe KD, Chang DC.

Surgery. 2017 Aug;162(2):203-210. doi: 10.1016/j.surg.2017.03.010. Epub 2017 May 11.

26.

Advocating for a Sensible Firearm Injury Prevention Plan.

Masiakos PT, Warshaw AL.

Ann Surg. 2018 May;267(5):e99-e100. doi: 10.1097/SLA.0000000000002272. No abstract available.

PMID:
28426478
27.

Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch-duct IPMN After 10 Years of Surveillance.

Honselmann KC, Patino M, Mino-Kenudson M, Ferrone C, Warshaw AL, Castillo CF, Lillemoe KD.

Ann Surg. 2017 Dec;266(6):e38-e40. doi: 10.1097/SLA.0000000000002238. No abstract available.

PMID:
28338512
28.

Cytologic characteristics of circulating epithelioid cells in pancreatic disease.

Rosenbaum MW, Cauley CE, Kulemann B, Liss AS, Castillo CF, Warshaw AL, Lillemoe KD, Thayer SP, Pitman MB.

Cancer Cytopathol. 2017 May;125(5):332-340. doi: 10.1002/cncy.21841. Epub 2017 Mar 3.

29.

Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Yamaguchi J, Mino-Kenudson M, Liss AS, Chowdhury S, Wang TC, Fernández-Del Castillo C, Lillemoe KD, Warshaw AL, Thayer SP.

Gastroenterology. 2016 Dec;151(6):1232-1244.e10. doi: 10.1053/j.gastro.2016.07.045. Epub 2016 Aug 12.

30.

Stopping the Bleeding Is Not Enough.

Masiakos PT, Warshaw AL.

Ann Surg. 2017 Jan;265(1):37-38. doi: 10.1097/SLA.0000000000001969. No abstract available.

PMID:
27611613
31.

The Hidden Consequences of the Volume Pledge: "No Patient Left Behind"?

Schwartz DM, Fong ZV, Warshaw AL, Zinner MJ, Chang DC.

Ann Surg. 2017 Feb;265(2):273-274. doi: 10.1097/SLA.0000000000001833. No abstract available.

PMID:
27280503
32.

Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.

Huang Y, Nahar S, Nakagawa A, Fernandez-Barrena MG, Mertz JA, Bryant BM, Adams CE, Mino-Kenudson M, Von Alt KN, Chang K, Conery AR, Hatton C, Sims RJ 3rd, Fernandez-Zapico ME, Wang X, Lillemoe KD, Fernández-Del Castillo C, Warshaw AL, Thayer SP, Liss AS.

Clin Cancer Res. 2016 Aug 15;22(16):4259-70. doi: 10.1158/1078-0432.CCR-15-2068. Epub 2016 May 11.

33.

Surgical Quality and Equity: Revisiting the Class of 1895.

Loehrer AP, Chang DC, Hutter MM, Warshaw AL.

Ann Surg. 2016 Aug;264(2):235-6. doi: 10.1097/SLA.0000000000001733. No abstract available.

PMID:
27058945
34.

Empowering the Public to Improve Survival in Mass Casualty Events.

Jacobs LM, Warshaw AL, Burns KJ.

Ann Surg. 2016 May;263(5):860-1. doi: 10.1097/SLA.0000000000001517. No abstract available.

PMID:
27058856
35.

Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.

Villani V, Mahadevan KK, Ligorio M, Fernández-Del Castillo C, Ting DT, Sabbatino F, Zhang I, Vangel M, Ferrone S, Warshaw AL, Lillemoe KD, Wargo J, Deshpande V, Ferrone CR.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):609-617. Epub 2016 Mar 28.

PMID:
27020585
36.

Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.

Deshpande V, Konstantinidis IT, Castillo CF, Hezel AF, Haigis KM, Ting DT, Bardeesy N, Goyal L, Zhu AX, Warshaw AL, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2016 May;20(5):953-9. doi: 10.1007/s11605-016-3108-0. Epub 2016 Mar 8.

PMID:
26956004
37.

Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains.

Nakagawa A, Adams CE, Huang Y, Hamarneh SR, Liu W, Von Alt KN, Mino-Kenudson M, Hodin RA, Lillemoe KD, Fernández-Del Castillo C, Warshaw AL, Liss AS.

Sci Rep. 2016 Feb 9;6:20390. doi: 10.1038/srep20390.

38.

Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital.

Sahora K, Morales-Oyarvide V, Ferrone C, Fong ZV, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):181-7. doi: 10.1002/jhbp.322. Epub 2016 Feb 23.

PMID:
26768943
39.

Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.

Zhang IY, Zhao J, Fernandez-Del Castillo C, Braun Y, Razmdjou S, Warshaw AL, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2016 Feb;20(2):277-83. doi: 10.1007/s11605-015-3043-5. Epub 2015 Dec 21.

PMID:
26691146
40.

Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.

Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw AL, Lillemoe K, Mino-Kenudson M, Falconi M, Fernandez-del Castillo C.

Eur J Surg Oncol. 2016 Feb;42(2):197-204. doi: 10.1016/j.ejso.2015.10.014. Epub 2015 Dec 1.

PMID:
26687069
41.

KRAS mutations in pancreatic circulating tumor cells: a pilot study.

Kulemann B, Liss AS, Warshaw AL, Seifert S, Bronsert P, Glatz T, Pitman MB, Hoeppner J.

Tumour Biol. 2016 Jun;37(6):7547-54. doi: 10.1007/s13277-015-4589-2. Epub 2015 Dec 18.

PMID:
26684803
42.

Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care?

Loehrer AP, Chang DC, Hutter MM, Song Z, Lillemoe KD, Warshaw AL, Ferrone CR.

J Am Coll Surg. 2015 Dec;221(6):1015-22. doi: 10.1016/j.jamcollsurg.2015.09.010. Epub 2015 Oct 9.

43.

A systematic response to mass trauma: The public, organized first responders, and the American College of Surgeons.

Warshaw AL.

Bull Am Coll Surg. 2015 Sep;100(1 Suppl):14-5. No abstract available.

PMID:
26477127
44.
45.

Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings.

Cauley CE, Pitman MB, Zhou J, Perkins J, Kuleman B, Liss AS, Fernandez-Del Castillo C, Warshaw AL, Lillemoe KD, Thayer SP.

J Am Coll Surg. 2015 Sep;221(3):699-707. doi: 10.1016/j.jamcollsurg.2015.05.014. Epub 2015 May 27.

46.

Pancreatic duct glands (PDGs) are a progenitor compartment responsible for pancreatic ductal epithelial repair.

Yamaguchi J, Liss AS, Sontheimer A, Mino-Kenudson M, Castillo CF, Warshaw AL, Thayer SP.

Stem Cell Res. 2015 Jul;15(1):190-202. doi: 10.1016/j.scr.2015.05.006. Epub 2015 May 19.

47.

Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

Surgery. 2015 Nov;158(5):1219-25. doi: 10.1016/j.surg.2015.04.029. Epub 2015 Jun 13.

PMID:
26077509
48.

Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms.

Sahora K, Ferrone CR, Brugge WR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1816-23. doi: 10.1016/j.cgh.2015.04.177. Epub 2015 May 6.

PMID:
25956837
49.

Lancet Commission. Editor's note.

Sarr MG, Behrns KE, Warshaw AL.

Surgery. 2015 May;157(5):833. doi: 10.1016/j.surg.2015.03.001. No abstract available.

PMID:
25934018
50.

Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.

Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

J Am Coll Surg. 2015 May;220(5):839-44. doi: 10.1016/j.jamcollsurg.2015.01.051. Epub 2015 Feb 11.

PMID:
25840549

Supplemental Content

Loading ...
Support Center